The South Korean Ministry of Food and Drug Safety granted an emergency authorization on Wednesday for Merck's COVID-19 pill, the second such treatment to be greenlighted after Pfizer's antiviral pill Paxlovid, Yonhap News Agency has reported.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3